Literature DB >> 25568815

Are Periventricular Lesions Specific for Multiple Sclerosis?

Gianna Casini1, Mary Yurashevich1, Rohini Vanga1, Subasini Dash1, Suhayl Dhib-Jalbut1, Brian Gerhardstein1, Matilde Inglese1, Win Toe1, Konstantin E Balashov1.   

Abstract

BACKGROUND: The presence of periventricular lesions (PVL) on MRI scans is part of the revised McDonald multiple sclerosis (MS) diagnostic criteria. However, PVL can be found in other neurological diseases including stroke and migraine. Migraine is highly prevalent in patients with MS.
OBJECTIVE: To determine if PVL are specific for patients with MS compared to stroke and migraine.
METHODS: We studied patients diagnosed with clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), migraine, and ischemic stroke. The number, location and the volume of PVL were identified on brain MRI scans and analyzed.
RESULTS: The number and volume of PVL adjacent to the body and the posterior horn of the lateral ventricles were significantly increased on fluid-attenuated inversion recovery MRI in RRMS compared to migraine. There were no significant differences in the total number and volume of PVL in ischemic stroke patients compared to the age-matched RRMS patients nor in the number and volume of PVL adjacent to the anterior and temporal horns of the lateral ventricles on FLAIR images in migraine compared to CIS or RRMS.
CONCLUSION: In contrast to PVL adjacent to the body and the posterior horn of the lateral ventricles, PVL adjacent to the anterior and temporal horns of the lateral ventricles may not be specific for CIS/RRMS when compared to migraine, the disease highly prevalent among patients with MS. PVL are not specific for MS when compared to ischemic stroke.

Entities:  

Keywords:  MRI; Migraine; Multiple sclerosis; Stroke

Year:  2013        PMID: 25568815      PMCID: PMC4283830          DOI: 10.4172/2155-9562.1000150

Source DB:  PubMed          Journal:  J Neurol Neurophysiol


  22 in total

1.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

2.  Using binary logistic regression models for ordinal data with non-proportional odds.

Authors:  R Bender; U Grouven
Journal:  J Clin Epidemiol       Date:  1998-10       Impact factor: 6.437

3.  Diffusion-weighted imaging in acute demyelinating myelopathy.

Authors:  Chiara Zecca; Carlo Cereda; Stephan Wetzel; Silvia Tschuor; Claudio Staedler; Francesco Santini; Navarajah Nadarajah; Claudio L Bassetti; Claudio Gobbi
Journal:  Neuroradiology       Date:  2011-07-09       Impact factor: 2.804

4.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  Acute demyelinating lesions with restricted diffusion in multiple sclerosis.

Authors:  Konstantin E Balashov; Eric Lindzen
Journal:  Mult Scler       Date:  2012-04-20       Impact factor: 6.312

6.  Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis.

Authors:  N Putzki; A Pfriem; V Limmroth; O Yaldizli; B Tettenborn; H C Diener; Z Katsarava
Journal:  Eur J Neurol       Date:  2008-12-09       Impact factor: 6.089

7.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

8.  Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria.

Authors:  C-P Lo; H-W Kao; S-Y Chen; C-J Hsueh; W-C Lin; W-L Hsu; D-K Wu; G-C Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06-21       Impact factor: 10.154

Review 9.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  1 in total

Review 1.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.